Literature DB >> 15177658

Carbohydrate-deficient transferrin (CDT) as a biomarker in persons suspected of alcohol abuse.

Klaus Golka1, Rolf Sondermann, Susanne E Reich, Andreas Wiese.   

Abstract

The coherence of carbohydrate-deficient transferrin (CDT) as a biomarker of alcohol abuse was investigated with 15 conventional laboratory parameters, with the self-reported medical history and with clinical findings, all previously reported to be associated with chronic alcohol intake. In total, 100 male persons who were at least suspected of abusing alcohol were assessed. Medical history, clinical picture and physical examination were taken, and laboratory parameters regarding blood count, liver enzymes, serum lipids, iron balance, Ig A and uric acid were determined. These data were correlated with the CDT values, the daily ethanol intakes reported, and several findings from medical history and clinical examination. The mean CDT level (mean+/-S.D.) of the entire group was 29.4+/-19.7 U/l. Eighty-one patients admitted a daily ethanol intake of 60 g or more. The ratio AST/ALT (de Ritis ratio) appeared as the best conventional parameter correlated with both CDT and ethanol intake. Mean corpuscular volume (MCV), serum iron, AST and red blood cell count also correlated significantly with CDT. CDT, AST and ferritin correlated significantly with the reported daily ethanol intake. It is concluded that CDT provides a reliable estimate of long-term alcohol intake.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15177658     DOI: 10.1016/j.toxlet.2004.01.023

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  5 in total

1.  Novel serum biomarkers for detection of excessive alcohol use.

Authors:  Suthat Liangpunsakul; Xianyin Lai; Ruth A Ross; Zhangsheng Yu; Elizabeth Modlik; Chi Westerhold; Laura Heathers; Robin Paul; Sean O'Connor; David W Crabb; Frank Witzmann
Journal:  Alcohol Clin Exp Res       Date:  2015-02-19       Impact factor: 3.455

2.  The Utility of Commonly Used Laboratory Tests to Screen for Excessive Alcohol Use in Clinical Practice.

Authors:  Gina Gough; Laura Heathers; Deonna Puckett; Chi Westerhold; Xiaowei Ren; Zhangsheng Yu; David W Crabb; Suthat Liangpunsakul
Journal:  Alcohol Clin Exp Res       Date:  2015-06-25       Impact factor: 3.455

Review 3.  Management of alcohol misuse in patients with liver diseases.

Authors:  Jennifer L Peng; Milan Prakash Patel; Breann McGee; Tiebing Liang; Kristina Chandler; Sucharat Tayarachakul; Sean O'Connor; Suthat Liangpunsakul
Journal:  J Investig Med       Date:  2016-12-09       Impact factor: 2.895

4.  Development and validation of a composite score for excessive alcohol use screening.

Authors:  Wanzhu Tu; Chenghao Chu; Shanshan Li; Suthat Liangpunsakul
Journal:  J Investig Med       Date:  2016-03-21       Impact factor: 2.895

Review 5.  Alpha-Synuclein in Alcohol Use Disorder, Connections with Parkinson's Disease and Potential Therapeutic Role of 5' Untranslated Region-Directed Small Molecules.

Authors:  Catherine M Cahill; Rozaleen Aleyadeh; Jin Gao; Changning Wang; Jack T Rogers
Journal:  Biomolecules       Date:  2020-10-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.